Good one.
I like the focus on mtor, I like less the idea that current mtor drugs ended up being dissapointing and the cancer became resistant quite quickly.
In saying that, the market for Sirolimus and Everolimus is still around 2.5b per annum according to the PAA slides....so while perhaps dissapointing in their trials, ultimately still financially profitable. Let's hope our mtor out performs massively in cancer trials (and covid)...
- Forums
- ASX - By Stock
- PAA
- Ann: Virtual Investor Briefing Presentation
Ann: Virtual Investor Briefing Presentation, page-149
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34313 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 24444 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9313 | 0.225 |
1 | 92000 | 0.220 |
5 | 50744 | 0.215 |
3 | 26203 | 0.210 |
4 | 27155 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 24444 | 2 |
0.240 | 25628 | 2 |
0.245 | 78609 | 3 |
0.250 | 65920 | 6 |
0.255 | 120000 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
22.5¢ |
  |
Change
-0.010 ( 6.25 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
Last updated 15.57pm 14/06/2024 ? |
Featured News
PAA (ASX) Chart |